Skip to main content
. 2019 Apr 24;10:873. doi: 10.3389/fimmu.2019.00873

Figure 5.

Figure 5

Evolution of miR-155-5p, miR-122-5p, and miR-181a-5p expression in patients experiencing subclinical rejection. An example of the evolution of the miR-155-5p, miR-122-5p, and miR-181a-5p expression in two patients with SCR. The arrow at 3 months post-transplantation indicates the time of the protocol biopsy. In patient #5, the second arrow indicates the time of the TCMAR episode.